For all your Regulatory Affairs challenges

News

EMA Releases Second Draft Guideline for consultation

The clinical investigation of medicinal products for the prevention of stroke and systemic embolic events in patients with non-valvular atrial fibrillation

 

http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500154227.pdf